Literature DB >> 26626782

Cardiovascular risk assessment with regadenoson SPECT MPI in patients with end-stage renal disease is safe, effective, and well tolerated: Does it matter?

Erica O Miller1, Ronald G Schwartz2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26626782     DOI： 10.1007/s12350-015-0337-7

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  19 in total

1.  Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO).

Authors:  Charles A Herzog; Richard W Asinger; Alan K Berger; David M Charytan; Javier Díez; Robert G Hart; Kai-Uwe Eckardt; Bertram L Kasiske; Peter A McCullough; Rod S Passman; Stephanie S DeLoach; Patrick H Pun; Eberhard Ritz
Journal:  Kidney Int       Date:  2011-07-13       Impact factor: 10.612

2.  Regadenoson pharmacokinetics and tolerability in subjects with impaired renal function.

Authors:  Toufigh Gordi; Brent Blackburn; Hsiao Lieu
Journal:  J Clin Pharmacol       Date:  2007-07       Impact factor: 3.126

3.  Global coronary flow reserve is associated with adverse cardiovascular events independently of luminal angiographic severity and modifies the effect of early revascularization.

Authors:  Viviany R Taqueti; Rory Hachamovitch; Venkatesh L Murthy; Masanao Naya; Courtney R Foster; Jon Hainer; Sharmila Dorbala; Ron Blankstein; Marcelo F Di Carli
Journal:  Circulation       Date:  2014-11-16       Impact factor: 29.690

4.  Attenuation of the side effect profile of regadenoson: a randomized double-blinded placebo-controlled study with aminophylline in patients undergoing myocardial perfusion imaging. "The ASSUAGE trial".

Authors:  Rami Doukky; Raysa Morales Demori; Sidharth Jain; Roy Kiriakos; Victor Mwansa; James E Calvin
Journal:  J Nucl Cardiol       Date:  2012-03-07       Impact factor: 5.952

5.  Enhanced detection of reversible perfusion defects by Tc-99m sestamibi compared to Tc-99m tetrofosmin during vasodilator stress SPECT imaging in mild-to-moderate coronary artery disease.

Authors:  P Soman; R Taillefer; E G DePuey; J E Udelson; A Lahiri
Journal:  J Am Coll Cardiol       Date:  2001-02       Impact factor: 24.094

6.  Severe chronic kidney disease as a predictor of benefit from aminophylline administration in patients undergoing regadenoson stress myocardial perfusion imaging: A substudy of the ASSUAGE and ASSUAGE-CKD trials.

Authors:  Maria Octavia Rangel; Raysa Morales Demori; Sarah T Voll; Marwan Wassouf; Rizcallah Dick; Rami Doukky
Journal:  J Nucl Cardiol       Date:  2014-12-11       Impact factor: 5.952

7.  The prognostic value of regadenoson myocardial perfusion imaging.

Authors:  Fadi G Hage; Gopal Ghimire; Davis Lester; Joshua Mckay; Steven Bleich; Stephanie El-Hajj; Ami E Iskandrian
Journal:  J Nucl Cardiol       Date:  2015-02-14       Impact factor: 5.952

8.  ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction).

Authors:  Elliott M Antman; Daniel T Anbe; Paul Wayne Armstrong; Eric R Bates; Lee A Green; Mary Hand; Judith S Hochman; Harlan M Krumholz; Frederick G Kushner; Gervasio A Lamas; Charles J Mullany; Joseph P Ornato; David L Pearle; Michael A Sloan; Sidney C Smith; Joseph S Alpert; Jeffrey L Anderson; David P Faxon; Valentin Fuster; Raymond J Gibbons; Gabriel Gregoratos; Jonathan L Halperin; Loren F Hiratzka; Sharon Ann Hunt; Alice K Jacobs
Journal:  Circulation       Date:  2004-08-03       Impact factor: 29.690

9.  Prognostic value of regadenoson myocardial single-photon emission computed tomography in patients with different degrees of renal dysfunction.

Authors:  Sabha Bhatti; Abdul Hakeem; Sunitha Dhanalakota; Gurunanthan Palani; Zehra Husain; Gordon Jacobsen; Karthik Ananthasubramaniam
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2014-04-03       Impact factor: 6.875

10.  Changes in quality of life after renal transplantation.

Authors:  R Jofré; J M López-Gómez; F Moreno; D Sanz-Guajardo; F Valderrábano
Journal:  Am J Kidney Dis       Date:  1998-07       Impact factor: 8.860
View more
  2 in total

Review 1.  Review of cardiovascular imaging in the Journal of Nuclear Cardiology in 2017. Part 2 of 2: Myocardial perfusion imaging.

Authors:  Fadi G Hage; Wael A AlJaroudi
Journal:  J Nucl Cardiol       Date:  2018-04-16       Impact factor: 5.952

2.  The association of secondary hyperparathyroidism and myocardial damages in hemodialysis end-stage renal disease patients: assessed by cardiovascular magnetic resonance native T1 mapping.

Authors:  Huayan Xu; Wanlin Peng; Zhigang Yang; Yingkun Guo; Yi Zhang; Chunchao Xia; Zhenlin Li; Rong Xu
Journal:  J Cardiovasc Magn Reson       Date:  2021-03-11       Impact factor: 5.364
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.